Histamine in the CNS: Multiple functions and potential neurologic implications

Neurology

Volumn 75, Issue 16, 2010, Pages 1472-1479

  Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE RECEPTOR;

ANATOMY; AROUSAL; BASAL GANGLION; CENTRAL NERVOUS SYSTEM FUNCTION; CIRCADIAN RHYTHM; MAMMILLARY BODY; METABOLISM; MOTOR DYSFUNCTION; NERVE CELL; NEUROCHEMISTRY; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; SYNTHESIS; ANIMAL; ARTICLE; CENTRAL NERVOUS SYSTEM; HISTOLOGY; HUMAN; MOUSE; NERVE TRACT; NEUROLOGIC DISEASE; PATHOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; HISTAMINE; HUMANS; MICE; NERVOUS SYSTEM DISEASES; NEURAL PATHWAYS; NEURONS; RECEPTORS, HISTAMINE;

EID: 78049493249     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f884b1     Document Type: Article

References (58)

1. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001;63:637-672.
2. Haas H, Panula P. The role of histamine and the tuberomammillary nucleus in the nervous system. Nat Rev Neurosci 2003;4:121-130.
3. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008;88:1183-1241.
4. Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol 2006;147(suppl 1):S127-S135.
5. Esbenshade TA, Browman KE, Bitner RS, Strakhova M, Cowart MD, Brioni JD. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol 2008;154:1166-1181.
6. Panula P, Airaksinen MS, Pirvola U, Kotilainen E. A histamine-containing neuronal system in human brain. Neuroscience 1990;34:127-132.
7. Airaksinen MS, Paetau A, Paljarvi L, et al. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 1991;44:465-481.
8. Moya-Garcia AA, Medina MA, Sanchez-Jimenez F. Mammalian histidine decarboxylase: from structure to function. Bioessays 2005;27:57-63.
9. Barnes WG, Hough LB. Membrane-bound histamine N-methyltransferase in mouse brain: possible role in the synaptic inactivation of neuronal histamine. J Neurochem 2002;82:1262-1271.
10. Preuss CV, Wood TC, Szumlanski CL, et al. Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol 1998;53:708-717.
11. Sander K, Kottke T, Stark H. Histamine H3 receptor antagonists go to clinics. Biol Pharm Bull 2008;31:2163-2181.
12. Steininger TL, Alam MN, Gong H, Szymusiak R, McGinty D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 1999;840:138-147.
13. Takahashi K, Lin JS, Sakai K. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 2006;26:10292-10298.
14. Giannoni P, Passani MB, Nosi D, et al. Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat. Eur J Neurosci 2009;29:2363-2374.
15. Abe H, Honma S, Ohtsu H, Honma K. Circadian rhythms in behavior and clock gene expressions in the brain of mice lacking histidine decarboxylase. Brain Res Mol Brain Res 2004;124:178-187.
16. Jacobs EH, Yamatodani A, Timmerman H. Is histamine the final neurotransmitter in the entrainment of circadian rhythms in mammals? Trends Pharmacol Sci 2000;21:293-298.
17. McCormick DA, Wang Z, Huguenard J. Neurotransmitter control of neocortical neuronal activity and excitability. Cereb Cortex 1993;3:387-398.
18. McCormick DA, Williamson A. Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal. J Neurosci 1991;11:3188-3199.
19. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005;437:1257-1263.
20. Burgess CR. Histamine and orexin in the control of arousal, locomotion, and motivation. J Neurosci 2010;30:2810-2811.
21. Siegel JM. Sleep viewed as a state of adaptive inactivity. Nat Rev Neurosci 2009;10:747-753.
22. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 2002;22:7695-7711.
23. Anaclet C, Parmentier R, Ouk K, et al. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009;29:14423-14438.
24. Tashiro M, Yanai K. [Molecular imaging of histamine receptors in the human brain.] Brain Nerve 2007;59:221-231.
25. Yokoyama H. The role of central histaminergic neuron system as an anticonvulsive mechanism in developing brain. Brain Dev 2001;23:542-547.
26. Chen Z, Li Z, Sakurai E, et al. Chemical kindling induced by pentylenetetrazol in histamine H (1) receptor gene knockout mice (H (1) KO), histidine decarboxylasedeficient mice (HDC (-/-)) and mast cell-deficient W/W (v) mice. Brain Res 2003;968:162-166.
27. Yawata I, Tanaka K, Nakagawa Y, Watanabe Y, Murashima YL, Nakano K. Role of histaminergic neurons in development of epileptic seizures in EL mice. Brain Res Mol Brain Res 2004;132:13-17.
28. Zhou FW, Xu JJ, Zhao Y, LeDoux MS, Zhou FM. Opposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulata. J Neurophysiol 2006;96:1581-1591.
29. Ogawa S, Yanai K, Watanabe T, et al. Histamine responses of large neostriatal interneurons in histamine H1 and H2 receptor knock-out mice. Brain Res Bull 2009;78:189-194.
30. Anichtchik OV, Peitsaro N, Rinne JO, Kalimo H, Panula P. Distribution and modulation of histamine H (3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 2001;8:707-716.
31. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science 2009;325:1531-1534.
32. Cannon KE, Hough LB. Inhibition of chemical and lowintensity mechanical nociception by activation of histamine H3 receptors. J Pain 2005;6:193-200.
33. Strakhova MI, Nikkel AL, Manelli AM, et al. Localization of histamine H4 receptors in the central nervous system of human and rat. Brain Res 2009;1250:41-48.
34. Kanbayashi T, Kodama T, Kondo H, et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 2009;32:181-187.
35. Zeitzer JM, Nishino S, Mignot E. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions. Trends Pharmacol Sci 2006;27:368-374.
36. Nishino S, Sakurai E, Nevsimalova S, et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 2009;32:175-180.
37. CB, German DC. Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 1987;74:364-370.
38. Airaksinen MS, Reinikainen K, Riekkinen P, Panula P. Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus. Agents Actions 1991;33:104-107.
39. Nakamura S, Takemura M, Ohnishi K, et al. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci Lett 1993;151:196-199.
40. Ishunina TA, van Heerikhuize JJ, Ravid R, Swaab DF. Estrogen receptors and metabolic activity in the human tuberomammillary nucleus: changes in relation to sex, aging and Alzheimer's disease. Brain Res 2003;988:84-96.
41. Higuchi M, Yanai K, Okamura N, et al. Histamine H (1) receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience 2000;99:721-729.
42. Medhurst AD, Roberts JC, Lee J, et al. Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice. Br J Pharmacol 2009;157:130-138.
43. Nowak P, Noras L, Jochem J, et al. Histaminergic activity in a rodent model of Parkinson's disease. Neurotox Res 2009;15:246-251.
44. Nakamura S, Ohnishi K, Nishimura M, et al. Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy. Neurology 1996;46:1693-1696.
45. Kremer HP, Bots GT. Lewy bodies in the lateral hypothalamus: do they imply neuronal loss? Mov Disord 1993;8:315-320.
46. Anichtchik OV, Rinne JO, Kalimo H, Panula P. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 2000;163:20-30.
47. Agundez JA, Luengo A, Herraez O, et al. Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease. Neuromolecular Med 2008;10:10-16.
48. Keeling BH, Vilarino-Guell C, Soto-Ortolaza AI, et al. Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor. Parkinsonism Relat Disord 2010;16:112-114.
49. Garcia-Martin E, Ayuso P, Luengo A, Martinez C, Agundez JA. Genetic variability of histamine receptors in patients with Parkinson's disease. BMC Med Genet 2008;9:15.
50. Ercan-Sencicek AG, Stillman AA, Ghosh AK, et al. L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 2010;362:1901-1908.
51. Nishida N, Huang ZL, Mikuni N, Miura Y, Urade Y, Hashimoto N. Deep brain stimulation of the posterior hypothalamus activates the histaminergic system to exert antiepileptic effect in rat pentylenetetrazol model. Exp Neurol 2007;205:132-144.
52. Jin CL, Zhuge ZB, Wu DC, et al. Lesion of the tuberomammillary nucleus E2-region attenuates postictal seizure protection in rats. Epilepsy Res 2007;73:250-258.
53. Yamashita Y, Isagai T, Seki Y, Ohya T, Nagamitsu S, Matsuishi T. West syndrome associated with administration of a histamine H1 antagonist, oxatomide. Kurume Med J 2004;51:273-275.
54. Haruyama W, Fuchigami T, Noguchi Y, et al. The relationship between drug treatment and the clinical characteristics of febrile seizures. World J Pediatr 2008;4:202-205.
55. Tiligada E, Zampeli E, Sander K, Stark H. Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 2009;18:1519-1531.
56. Passani MB, Lin JS, Hancock A, Crochet S, Blandina P. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 2004;25:618-625.
57. Lin JS, Dauvilliers Y, Arnulf I, et al. An inverse agonist of the histamine H (3) receptor improves wakefulness in narcolepsy: studies in orexin -/- mice and patients. Neurobiol Dis 2008;30:74-83.
58. Medhurst SJ, Collins SD, Billinton A, et al. Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain. Pain 2008;138:61-69.